These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 5947842
1. [The bile acids in primary biliary cirrhosis. Comparison with other hepatic diseases]. Rautureau M, Lemonnier F, Chevrel B. Rev Int Hepatol; 1966; 16(2):193-205. PubMed ID: 5947842 [No Abstract] [Full Text] [Related]
2. [Bile acid examinations in blood and urine of icteric and non-icteric with various liver diseases]. Wildgrube HJ, Dittmann K, Erb W. Verh Dtsch Ges Inn Med; 1974; 80():448-50. PubMed ID: 4454583 [No Abstract] [Full Text] [Related]
3. Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis. Batta AK, Salen G, Mirchandani R, Tint GS, Shefer S, Batta M, Abroon J, O'Brien CB, Senior JR. Am J Gastroenterol; 1993 May; 88(5):691-700. PubMed ID: 8480734 [Abstract] [Full Text] [Related]
4. The pathophysiology of cholestasis with special reference to primary biliary cirrhosis. Jansen PL. Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):571-83. PubMed ID: 10976015 [Abstract] [Full Text] [Related]
5. Determination of gallbladder bile lithogenicity in patients with primary biliary cirrhosis. Fracchia M, Jazrawi RP, Galatola G. Ital J Gastroenterol; 1996 Jun; 28(5):255-60. PubMed ID: 8842843 [Abstract] [Full Text] [Related]
9. Determination of serum bile acids in hepatobiliary diseases by gas liquid chromatography (fasting serum bile acid levels and endogenous bile acid tolerance test). Kajiyama G, Fukuhara C, Oyamada K, Horiuchi I, Nakagawa M, Takata K, Miyoshi A. Hiroshima J Med Sci; 1981 Dec; 30(4):263-71. PubMed ID: 6765677 [No Abstract] [Full Text] [Related]
10. [Protein-copper complex in primary biliary cirrhosis and other chronic diffuse diseases of the liver]. Loginov AS, Aruin LI, Shepeleva SD. Arkh Patol; 1980 Dec; 42(4):50-5. PubMed ID: 7396755 [Abstract] [Full Text] [Related]
14. Hepatic subcellular distribution of copper in primary biliary cirrhosis. Comparison with other hyperhepatocupric states and review of the literature. Owen CA, Dickson ER, Goldstein NP, Baggenstoss AH, McCall JT. Mayo Clin Proc; 1977 Feb; 52(2):73-80. PubMed ID: 345001 [No Abstract] [Full Text] [Related]
15. Rationale for therapy with ursodeoxycholic acid in patients with cholestatic liver disease. van Erpecum KJ, van de Meeberg PC, van Berge Henegouwen GP. Neth J Med; 1993 Dec; 43(5-6):233-8. PubMed ID: 8107930 [Abstract] [Full Text] [Related]
17. The significance of bile acids in gastrointestinal and hepatic disease. Hofmann AF, Kern F. Dis Mon; 1971 Nov; ():3-38. PubMed ID: 4942747 [No Abstract] [Full Text] [Related]